Evidence map›Paper›PMID 37827570›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2024

Temporal course of cognitive and behavioural changes in motor neuron diseases.

Caroline A McHutchison, Joanne Wuu, Corey T McMillan, Rosa Rademakers, Jeffrey Statland, Gang Wu, Evadnie Rampersaud, Jason Myers, Jessica P Hernandez, Sharon Abrahams and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mild cognitive impairment in amyotrophic lateral sclerosis: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  7. The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Caroline A McHutchisonSchool of Philosophy, Psychology, and Language Sciences, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-0103-8580
Joanne WuuDepartment of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Corey T McMillanDepartment of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-7581-6405
Rosa RademakersDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-4049-0863
Jeffrey StatlandDepartment of Neurology, The University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID 0000-0003-0790-5315
Gang WuDepartment of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Evadnie RampersaudDepartment of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jason MyersDepartment of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jessica P HernandezDepartment of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.ORCID 0000-0002-2436-7689
Sharon AbrahamsSchool of Philosophy, Psychology, and Language Sciences, The University of Edinburgh, Edinburgh, UK.
Michael BenatarDepartment of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA MBenatar@med.miami.edu.ORCID 0000-0003-4241-5135
CReATe Consortium
St. Jude Children's Research Hospital · USUniversity of Miami · USUniversity of Edinburgh · GBUniversity of Antwerp · BEUniversity of Kansas Medical Center · USUniversity of Pennsylvania · US

Funding

Uncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Michael Benatar · 2014 to 2026
$19.8M
NINDS NIH HHS U54 NS092091
6 · The paper itself

Abstract

backgroundCognitive and behavioural dysfunction may occur in people with motor neuron disease (MND), with some studies suggesting an association with the

methodsParticipants with MND were recruited through the Phenotype-Genotype-Biomarker study. Every 3-6 months, the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was used to assess amyotrophic lateral sclerosis (ALS) specific (executive functioning, verbal fluency, language) and ALS non-specific (memory, visuospatial) functions. Informants reported on behaviour symptoms via semi-structured interview.

resultsParticipants with neuropsychological data at ≥3 visits were included (n=237, mean age=59, 60% male), of which 18 (8%) were

conclusionsIn this study, cognitive dysfunction was less common than previously reported and remained stable over time for most. However, cognition declines longitudinally in a small subset, which is not entirely related to

Indexed as

Amyotrophic Lateral SclerosisCognitive DysfunctionMotor Neuron DiseaseC9orf72 ProteinCognitionFemaleHumansMaleMiddle AgedNeuropsychological TestsC9orf72 ProteinALSC9ORFCOGNITIONFRONTOTEMPORAL DEMENTIAMOTOR NEURON DISEASE

Identifiers

PMID37827570
PMCPMC10958376
OpenAlexW4387580335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.